Improving Fertility in Non-obstructive Azoospermia: Results from an Autologous Bone Mar-row-Derived Mesenchymal Stromal/Stem Cell Phase I Clinical Trial.

Rano Zhankina; Ulanbek Zhanbyrbekuly; Manarbek Askarov; Afshin Zare; Nazanin Jafari; Dana Saipiyeva; Ravil Sherkhanov; Daniyar Akhmetov; Alireza Hashemi; Mojtaba Farjam; Nader Tanideh; Behrouz Aflatoonian; Nadiar M. Mussin; Asset Askerovich Kaliyev; Yerlan Sultangereyev; Hanieh Baneshi; Reza Shirazi; Mahdi Mahdipour; Shabnam Bakhshalizadeh; Farhad Rahmanifar; Amin Tamadon

doi:10.22074/ijfs.2023.2005045.1480

Abstract

In this phase I clinical trial, our primary objective was to develop an innovative therapeutic approach utilizing autologous bone marrow-derived mesenchymal stromal/stem cells (BM-MSCs) for the treatment of nonobstructive azoospermia (NOA). Additionally, we aimed to assess the feasibility and safety of this approach.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhankina et al. (2024) studied this question.

synapsesocial.com/papers/68e60785b6db64358759ab0b https://doi.org/10.22074/ijfs.2023.2005045.1480

View at Publisher

Ask AI

Bookmark

Share

Improving Fertility in Non-obstructive Azoospermia: Results from an Autologous Bone Mar-row-Derived Mesenchymal Stromal/Stem Cell Phase I Clinical Trial.

Abstract

Discussion

Cite This Study

Improving Fertility in Non-obstructive Azoospermia: Results from an Autologous Bone Mar-row-Derived Mesenchymal Stromal/Stem Cell Phase I Clinical Trial.

Abstract

Discussion

Cite This Study

Keep reading

Keep reading